Boosting the immunogenicity of the CoronaVac SARS-CoV-2 inactivated vaccine with Huoxiang Suling Shuanghua Decoction: a randomized, double-blind, placebo-controlled study.
Tang R, Wang L, Zhang J, Fei W, Zhang R, Liu J, Lv M, Wang M, Lv R, Nan H, Tao R, Chen Y, Chen Y, Jiang Y, Zhang H.
Tang R, et al.
Front Immunol. 2024 Apr 3;15:1298471. doi: 10.3389/fimmu.2024.1298471. eCollection 2024.
Front Immunol. 2024.
PMID: 38633263
Free PMC article.
Clinical Trial.
Safety aspects were assessed by recording local and systemic adverse events, and by blood and urine biochemistry and liver and kidney function tests. Main outcomes evaluated included serum anti-RBD IgG titer, T lymphocyte subsets, serum IgG and IgM levels, complement compo …
Safety aspects were assessed by recording local and systemic adverse events, and by blood and urine biochemistry and liver and kidney functi …